This announcement is a separate document:
康弘药业：关于2021年股票期权激励计划预留授予部分第二个行权期自主行权的提示性公告
Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan to reserve the right to exercise independently during part of the second exercise period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.